Skip to main content
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 39.62
Day High 40.64
Open:40.64
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Zymeworks to Present at Upcoming Investor Conferences
- BusinessWire - Thu Sep 3, 7:30AM CDT
BusinessWire - CMTX
Thu Sep 3, 7:30AM CDT
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will participate in three upcoming virtual investor conferences.
Zymeworks Reports 2020 Second Quarter Financial Results
- BusinessWire - Wed Aug 5, 3:15PM CDT
BusinessWire - CMTX
Wed Aug 5, 3:15PM CDT
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the quarter ended June 30, 2020.
Zymeworks to Present at the Jefferies 2020 Virtual Healthcare Conference
- BusinessWire - Thu May 28, 7:30AM CDT
BusinessWire - CMTX
Thu May 28, 7:30AM CDT
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that the Company will present at the upcoming Jefferies 2020 Virtual Healthcare Conference taking place June 2-4, 2020.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 39.62 +0.66% increase
on 10/28/20
Period Open:44.98
Price movement based on the high, low and last over the given period.
47.45 -15.95% decrease
on 10/12/20
-5.10 (-11.34%) decrease
since 09/28/20
3-Month 28.71 +38.91% increase
on 08/17/20
Period Open:29.81
Price movement based on the high, low and last over the given period.
47.45 -15.95% decrease
on 10/12/20
+10.07 (+33.78%) increase
since 07/28/20
52-Week 20.33 +96.16% increase
on 03/18/20
Period Open:31.55
Price movement based on the high, low and last over the given period.
52.75 -24.40% decrease
on 01/22/20
+8.33 (+26.40%) increase
since 10/28/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies